VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+10.35%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$113M
AUM Growth
+$113M
(-1.9%)
Cap. Flow
-$8.35M
Cap. Flow
% of AUM
-7.38%
Top 10 Holdings %
Top 10 Hldgs %
14.17%
Holding
280
New
34
Increased
62
Reduced
100
Closed
19
Top Buys
| 1 |
Fidelity MSCI Financials Index ETF
FNCL
|
$1.41M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.15M |
| 3 |
Verastem
VSTM
|
$985K |
| 4 |
Arrowhead Research
ARWR
|
$933K |
| 5 |
Cartesian Therapeutics
RNAC
|
$884K |
Top Sells
Sector Composition
| 1 | Healthcare | 77.9% |
| 2 | Financials | 0.8% |
| 3 | Technology | 0.58% |
| 4 | Consumer Discretionary | 0.4% |
| 5 | Energy | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
76
DELISTED
Seagen Inc. Common Stock
SGEN
| $740K | 0.65% | 11,148 -6,332 | -36% | -$420K |
|
77
CytomX Therapeutics
CTMX
$336M
| $739K | 0.65% | 32,334 -2,542 | -7% | -$58.1K |
|
|
KDNY
78
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $738K | 0.65% | 105,398 +13,000 | +14% | +$91K |
|
|
STML
79
DELISTED
Stemline Therapeutics, Inc.
STML
| $736K | 0.65% | 45,850 -5,828 | -11% | -$93.6K |
|
80
Sangamo Therapeutics
SGMO
$157M
| $734K | 0.65% | 51,691 +5,242 | +11% | +$74.4K |
|
81
Voyager Therapeutics
VYGR
$186M
| $733K | 0.65% | 37,502 -15,905 | -30% | -$311K |
|
|
AIMT
82
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $733K | 0.65% | 27,252 +5,151 | +23% | +$139K |
|
83
Xencor
XNCR
$580M
| $732K | 0.65% | 19,772 -15,782 | -44% | -$584K |
|
|
MDCO
84
DELISTED
Medicines Co
MDCO
| $730K | 0.65% | 19,897 -13,374 | -40% | -$491K |
|
85
Direxion Daily Utilities Bull 3X Shares
UTSL
$29.8M
| $727K | 0.64% | +28,402 | New | +$727K |
|
|
FPRX
86
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $727K | 0.64% | 46,007 +9,879 | +27% | +$156K |
|
|
CELG
87
DELISTED
Celgene Corp
CELG
| $727K | 0.64% | 9,159 +845 | +10% | +$67.1K |
|
|
PGNX
88
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $725K | 0.64% | +90,177 | New | +$725K |
|
|
CLVS
89
DELISTED
Clovis Oncology, Inc.
CLVS
| $724K | 0.64% | 15,930 +1,827 | +13% | +$83K |
|
90
Akebia Therapeutics
AKBA
$833M
| $723K | 0.64% | 72,408 +21,946 | +43% | +$219K |
|
91
United Therapeutics
UTHR
$13.8B
| $723K | 0.64% | 6,394 -314 | -5% | -$35.5K |
|
92
Neurocrine Biosciences
NBIX
$13.8B
| $717K | 0.63% | 7,296 -5,603 | -43% | -$551K |
|
|
RETA
93
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $716K | 0.63% | 20,484 -9,604 | -32% | -$336K |
|
94
Geron
GERN
$893M
| $714K | 0.63% | 208,093 -171,337 | -45% | -$588K |
|
95
Travere Therapeutics
TVTX
$1.56B
| $714K | 0.63% | 26,176 -15,627 | -37% | -$426K |
|
96
Cytokinetics
CYTK
$4.23B
| $713K | 0.63% | 85,880 -7,429 | -8% | -$61.7K |
|
97
PTC Therapeutics
PTCT
$3.92B
| $713K | 0.63% | 21,140 -25,777 | -55% | -$869K |
|
|
DOVA
98
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $707K | 0.63% | 23,637 +410 | +2% | +$12.3K |
|
|
ONC
99
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $705K | 0.62% | 4,587 -3,495 | -43% | -$537K |
|
100
Dynavax Technologies
DVAX
$1.19B
| $700K | 0.62% | 45,914 -1,984 | -4% | -$30.2K |
|